Opportunity

Simpler Grants.gov #362731

CDC Forecasts Grant for Integrated Viral Hepatitis Surveillance and Prevention Programs

Buyer

Centers for Disease Control - NCHHSTP

Posted

June 09, 2026

Respond By

December 09, 2026

Identifier

362731

NAICS

923120

This opportunity is a forecasted grant from the Centers for Disease Control and Prevention (CDC) - National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) to support integrated viral hepatitis surveillance and prevention programs for health departments in the US. - Government Buyer: - Centers for Disease Control and Prevention (CDC) - National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) - OEMs and Vendors: - No specific OEMs or commercial vendors are named; this is a grant for public health agencies - Products/Services Requested: - Support for integrated viral hepatitis surveillance and prevention programs - Outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C - Activities include: - Developing disease registries - Conducting data matching - Generating data summaries - Monitoring program progress - Enhancing case investigations - Strengthening health department infrastructure - Elimination planning and partnerships - Increasing testing and treatment for hepatitis B and C - Service integration in high-impact settings - Developing perinatal hepatitis C programs - Unique or Notable Requirements: - The NOFO is structured with two required components (Outbreak Response and Surveillance; Planning, Partnerships, and Promotion) and two optional components (Testing, Treatment, and Prevention; Perinatal Hepatitis C Program) - Up to 60 awards are expected - Estimated total funding is $450 million - Eligible applicants are state, local, and territorial health agencies

Description

This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. It includes key strategies such as outbreak response and surveillance for hepatitis A, B, and C, development of disease registries, data matching, and enhancing case investigations. The program aims to improve surveillance, strategic planning, partner collaboration, and expand access to prevention, diagnosis, and treatment in high-impact settings. The NOFO has two required components (Outbreak Response and Surveillance; Planning, Partnerships, and Promotion) and two optional components (Testing, Treatment, and Prevention; Perinatal Hepatitis C Program).

View original listing